Prostate Cancer
Prostate cancer detection rate at second and third biopsy. Predictive factors and risk groups for cancer diagnosis - Abstract
November 12, 2014
Incorporation of detailed family history from the Swedish Family-Cancer Database into the Prostate Cancer Prevention Trial Risk Calculator - Abstract
November 11, 2014
Incidence of second malignancies in prostate cancer patients treated with low-dose-rate brachytherapy and radical prostatectomy - Abstract
November 11, 2014
Oncologic and quality-of-life outcomes with wide resection in robot-assisted laparoscopic radical prostatectomy - Abstract
November 11, 2014
Development and validation of a prognostic index for fracture risk in older men undergoing prostate cancer treatment - Abstract
November 11, 2014
The importance of perceived stress management skills for patients with prostate cancer in active surveillance - Abstract
November 8, 2014
The real practice of antibiotic prophylaxis for prostate biopsy in Korea where the prevalence of quinolone-resistant Escherichia coli is high - Abstract
November 8, 2014
Trans-Pacific variation in outcomes for men treated with primary androgen deprivation therapy for prostate cancer - Abstract
November 8, 2014
Diagnosis and management of local recurrence after low-dose-rate brachytherapy - Abstract
November 8, 2014
Tissue composition and density impact on the clinical parameters for 125I prostate implants dosimetry - Abstract
November 8, 2014
Long-term survival of extremely advanced prostate cancer patients diagnosed with prostate-specific antigen over 500 ng/ml - Abstract
November 8, 2014
Quo vadis: Advanced prostate cancer-clinical care and clinical research in the era of multiple androgen receptor-directed therapies - Abstract
November 8, 2014